middle.news
How Resonance Health Plans to Hit $17M Revenue in FY26
4:11am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Resonance Health Plans to Hit $17M Revenue in FY26
4:11am on Saturday 30th of August, 2025 AEST
Key Points
FY25 revenue up 29% to $11.1M with 24% EBITDA growth
Three complementary profit centers, SaMD, CRO, and Investigator Sites
Major clinical trial contracts worth $20.1M secured since August 2023
FY26 guidance projects $17M revenue and $2M underlying EBITDA
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE